Formosa Pharmaceuticals
Manufacturing · Taiwan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8f-6 No. 57 Fuxing North Rd, Taipei City...Phone Number
+886 227557659Website
www.formosapharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Formosa Pharmaceuticals
Formosa Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in ophthalmology, oncology, and anti-infectives. The company is focused on developing innovative therapies through a unique pipeline that includes risk-diverse development modes and proprietary nanoparticle formulation platforms. Their intended clients include healthcare providers and patients in need of advanced treatments for ocular diseases and cancer. Formosa Pharmaceuticals actively engages in licensing agreements to commercialize their products and enhance patient care.Explore more
Formosa Pharmaceuticals Org Chart
LT
Director, Finance & Administration
KY
Director, CMC & Production
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Formosa Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Formosa Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Formosa Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Formosa Pharmaceuticals
Website visits: Recent activity has been detected on your website
Check out if Formosa Pharmaceuticals is spiking on competitors!
Click to see if Formosa Pharmaceuticals had a recent Job posting/layoffs
Check if Formosa Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Formosa Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Formosa Pharmaceuticals has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Formosa Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Formosa Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Formosa Pharmaceuticals.
Formosa Pharmaceuticals Tech Stack
A closer look at the technologies used by Formosa Pharmaceuticals
Formosa Pharmaceuticals News & Media
Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
TAIPEI, May 21, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. announces that its abstract highlighting the differentiated binding profile and preclinical efficacy of TSY-310, a novel bispecific antibody-drug conjugate (ADC), has been selected for presentation at the American Society...Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases
SINGAPORE and TAIPEI, April 30, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. ("Formosa", 6838.TW) and the Singapore Eye Research Institute ("SERI") are pleased to announce a strategic research collaboration to develop next-generation ophthalmic formulations. This partnership will...Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
TAIPEI, Feb. 23, 2026 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Arrotex Pharmaceuticals Pty Ltd. ("Arrotex"), for exclusive rights to the commercialization of clobetasol...Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
TAIPEI, Feb. 23, 2026 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Arrotex Pharmaceuticals Pty Ltd. ("Arrotex"), for exclusive rights to the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), an innovative topical eyedrop for the treatment of inflammation and pain following ocular surgery in Australia and New Zealand. Arrotex, 'Australia's Medicine
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Formosa Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Formosa Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in ophthalmology, oncology, and anti-infectives. The company is focused on developing innovative therapies through a unique pipeline that includes risk-diverse development modes and proprietary nanoparticle formulation platforms. Their intended clients include... Read More
